Hilla Ben-Pazi: AMIT301 Receives Approval in Israel for Continuous Stroke Monitoring
Hilla Ben-Pazi, Founder and CEO of Avertto Medical LTD, shared on LinkedIn:
”We are excited to share that Avertto has received approval to begin selling AMIT301 in the Israeli market — an important milestone for our company and for the future of continuous stroke monitoring.
AMIT301 is named in memory of the brave paramedic Amit Man, whose dedication to saving lives continues to inspire us every day.
Her legacy lives on through our mission: developing technologies to detect critical cerebrovascular changes earlier and improve patient outcomes.
For those less familiar with the Israeli regulatory pathway, this milestone signifies successful local registration and paves the way for early clinical adoption in Israel.
We are also looking forward to working with our early Israeli adopters, Shady Jahshan, Hillit Cohen, and David Orion, and learning from their feedback as we continue to improve and expand the platform.
It is also a reminder of the strength of the Israeli innovation ecosystem — where medicine, engineering, clinical collaboration, and entrepreneurship come together to transform bold ideas into life-saving technologies.
A huge thank you to our incredible team, Asher Kuper, Kety Bardugo, Yair Lavi, Meron Ben Pazi, and Lior Elmaliach, for the dedication, persistence, and hard work that made this possible.
This achievement belongs to all of you.”
Stay updated with Hemostasis Today.
-
May 31, 2026, 13:11Wolfgang Miesbach: From CD20 to CD38 – A New Dimension in ITTP Therapy
-
May 31, 2026, 13:05Ellia Tootoonchian: Advancing Equitable Care Through Global Collaboration at WFH 2026
-
May 31, 2026, 12:55Rishiraj Sinha: Transfusion Evidence Library Round-Up – International Thalassaemia Day 2026
-
May 31, 2026, 12:40Tareq Abadl: Key Differences Between Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura
-
May 31, 2026, 12:37Jeyaraj Pandian: World Stroke Organization Advances Stroke Education and Care in Central Asia
-
May 31, 2026, 12:31Stephen James Ryan: We Validated the Norwegian Version of the Vision Impairment Screening Assessment in Stroke
-
May 31, 2026, 12:01Sheila Cristina Ouriques Martins: We Provide Practical, Real-World Examples on How to Implement Stroke Prevention Strategies
-
May 31, 2026, 11:51Seema Dawood: Principles of Blood Smear Examination and Interpretation
-
May 31, 2026, 11:45Maria Cherska: Should We Continue Relying on Risk Prediction or Shift to Direct Detection of Atherosclerosis?